NVS: Novartis AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 182,877.37
Enterprise Value ($M) 202,287.37
Book Value ($M) 61,704.00
Book Value / Share 28.41
Price / Book 2.96
NCAV ($M) -26,278.00
NCAV / Share -12.10
Price / NCAV -6.96

Profitability (mra)
Return on Invested Capital (ROIC) 0.25
Return on Assets (ROA) 0.20
Return on Equity (ROE) 0.48

Liquidity (mrq)
Quick Ratio 1.01
Current Ratio 1.25

Balance Sheet (mrq) ($M)
Current Assets 37,236.00
Assets 125,218.00
Liabilities 63,514.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 52,877.00
Operating Income 13,036.00
Net Income 24,021.00

Cash Flow Statement (mra) ($M)
Cash From Operations 15,071.00
Cash from Investing 4,208.00
Cash from Financing -16,264.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-04 13G BlackRock Inc. 5.70

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-06-28 117,660 1,502,922 7.83
2022-06-27 224,683 1,946,266 11.54
2022-06-24 137,265 1,774,862 7.73
2022-06-23 149,059 1,652,692 9.02

(click for more detail)

(click for list of largest short owners)

Similar Companies
MYOV – Myovant Sciences Ltd. NUVB – Nuvation Bio Inc
NVO – Novo-Nordisk A/S OGN – Organon & Co.
PBH – Prestige Brands Holdings, Inc.


Financial data and stock pages provided by
Fintel.io